NFE2L2 and acute myeloid leukemia: In AML, USP15 is found upregulated compared with normal hematopoietic progenitor cells, and its inhibition, together with the following activation of NRF2 (nuclear factor 2-related erythroid factor 2), leads to redox (oxidation-reduction) perturbations.